{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:21:32Z","timestamp":1776777692731,"version":"3.51.2"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","theclinics.com","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.cld.2014.09.005","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T23:48:39Z","timestamp":1416527319000},"page":"81-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Diagnosis and Management of Overlap Syndromes"],"prefix":"10.1016","volume":"19","author":[{"given":"Chalermrat","family":"Bunchorntavakul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Rajender","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cld.2014.09.005_bib1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2036.2012.05223.x","article-title":"Review article: overlap syndromes and autoimmune liver disease","volume":"36","author":"Trivedi","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cld.2014.09.005_bib2","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib3","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2014.09.005_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2014.09.005_bib5","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.cgh.2013.08.039","article-title":"Cholestatic phenotypes of autoimmune hepatitis","volume":"12","author":"Czaja","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2014.09.005_bib7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1155\/2013\/198070","article-title":"Diagnosis and management of the overlap syndromes of autoimmune hepatitis","volume":"27","author":"Czaja","year":"2013","journal-title":"Can J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2014.09.005_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/cld.317","article-title":"Overlap syndrome: a real syndrome?","volume":"3","author":"Haldar","year":"2014","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib9","first-page":"326","article-title":"The overlap syndromes of autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1016\/j.cld.2014.09.005_bib10","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1023\/A:1010620122567","article-title":"A\u00a0case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis: a new overlap of autoimmune liver diseases","volume":"46","author":"Burak","year":"2001","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.cld.2014.09.005_bib11","first-page":"360","article-title":"Primary biliary cirrhosis-primary sclerosing cholangitis overlap syndrome","volume":"108","author":"Rubel","year":"1984","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cld.2014.09.005_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/IJGM.S11201","article-title":"Overlap of primary biliary cirrhosis and primary sclerosing cholangitis - a rare coincidence or a new syndrome","volume":"3","author":"Jeevagan","year":"2010","journal-title":"Int J Gen Med"},{"issue":"10","key":"10.1016\/j.cld.2014.09.005_bib13","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/00042737-200510000-00011","article-title":"Co-existence of primary biliary cirrhosis and primary sclerosing cholangitis: a rare overlap syndrome put in perspective","volume":"17","author":"Kingham","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2014.09.005_bib14","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2014.09.005_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2014.09.005_bib16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-0029-1233532","article-title":"Scoring systems for the diagnosis of autoimmune hepatitis: past, present, and future","volume":"29","author":"Wiegard","year":"2009","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2014.09.005_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/cld.294","article-title":"Overlap syndromes","volume":"3","author":"Czaja","year":"2014","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.cld.2014.09.005_bib19","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ajg.2008.161","article-title":"Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis","volume":"104","author":"Bangarulingam","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.7156\/v5i2p082","article-title":"Primary sclerosing cholangitis: from pathogenesis to medical management","volume":"5","author":"Bunchorntavakul","year":"2012","journal-title":"N\u00a0A J Med Sci"},{"issue":"3","key":"10.1016\/j.cld.2014.09.005_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1089-3261(02)00021-1","article-title":"Prevalence and epidemiology of autoimmune hepatitis","volume":"6","author":"Boberg","year":"2002","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.cld.2014.09.005_bib22","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a US community","volume":"119","author":"Kim","year":"2000","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2014.09.005_bib23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1089-3261(03)00102-8","article-title":"The epidemiology of primary biliary cirrhosis","volume":"7","author":"Prince","year":"2003","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/jhep.2002.30902","article-title":"Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid","volume":"35","author":"Joshi","year":"2002","journal-title":"Hepatology"},{"issue":"9039","key":"10.1016\/j.cld.2014.09.005_bib27","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cld.2014.09.005_bib28","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/0016-5085(93)90160-E","article-title":"Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2014.09.005_bib29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2014.09.005_bib30","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cgh.2010.03.004","article-title":"Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome","volume":"8","author":"Kuiper","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2014.09.005_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.21229","article-title":"Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis","volume":"44","author":"Poupon","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0168-8278(05)80394-0","article-title":"Autoimmune chronic active hepatitis responsive to immunosuppressive therapy evolving into a typical primary biliary cirrhosis syndrome: a case report","volume":"21","author":"Horsmans","year":"1994","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2014.09.005_bib33","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejim.2008.12.011","article-title":"Transitions between variant forms of primary biliary cirrhosis during long-term follow-up","volume":"20","author":"Lindgren","year":"2009","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10.1016\/j.cld.2014.09.005_bib34","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1440-1746.2004.03372.x","article-title":"Clinical and pathological characteristics of the autoimmune hepatitis and primary biliary cirrhosis overlap syndrome","volume":"19","author":"Suzuki","year":"2004","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2014.09.005_bib35","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2014.09.005_bib36","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/gast.2002.31880","article-title":"Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients","volume":"122","author":"Corpechot","year":"2002","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2014.09.005_bib37","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2008.07.019","article-title":"Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment","volume":"135","author":"Huet","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2014.09.005_bib38","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","article-title":"Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals","volume":"29","author":"Lohse","year":"1999","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","article-title":"Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome","volume":"44","author":"Chazouilleres","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2014.09.005_bib40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2036.2011.04727.x","article-title":"The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes","volume":"34","author":"Baven-Pronk","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.cld.2014.09.005_bib41","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/BF02064201","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A","volume":"40","author":"Duclos-Vallee","year":"1995","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.cld.2014.09.005_bib42","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2014.09.005_bib43","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1572-0241.1998.224_a.x","article-title":"Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases","volume":"93","author":"McNair","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2014.09.005_bib44","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1600-0641.2000.033004543.x","article-title":"High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis","volume":"33","author":"van Buuren","year":"2000","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2014.09.005_bib45","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/jhep.2002.37200","article-title":"Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome","volume":"36","author":"Abdo","year":"2002","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2014.09.005_bib46","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2014.09.005_bib47","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","article-title":"Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system","volume":"33","author":"Kaya","year":"2000","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib48","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hep.23024","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study","volume":"50","author":"Lewin","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2014.09.005_bib49","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.22073","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging","volume":"47","author":"Abdalian","year":"2008","journal-title":"Hepatology"},{"issue":"2\u20133","key":"10.1016\/j.cld.2014.09.005_bib50","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0168-8278(92)90178-R","article-title":"Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis","volume":"14","author":"Perdigoto","year":"1992","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2014.09.005_bib51","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival","volume":"28","author":"Al-Chalabi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejim.2008.06.004","article-title":"High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis","volume":"20","author":"Olsson","year":"2009","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.cld.2014.09.005_bib54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MCG.0b013e318157c614","article-title":"Characteristics and long-term prognosis of the autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"43","author":"Luth","year":"2009","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib55","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cld.2012.03.010","article-title":"Pruritus in chronic cholestatic liver disease","volume":"16","author":"Bunchorntavakul","year":"2012","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.cld.2014.09.005_bib56","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00042737-200406000-00012","article-title":"Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and primary cholestatic liver disease","volume":"16","author":"Gheorghe","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2014.09.005_bib57","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/0891693021000064272","article-title":"The hepatitic\/cholestatic \u201coverlap\u201d syndrome: an Italian experience","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.cld.2014.09.005_bib58","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/jhep.2000.7878","article-title":"Autoimmune cholangitis within the spectrum of autoimmune liver disease","volume":"31","author":"Czaja","year":"2000","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib59","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1034\/j.1600-0676.2003.00810.x","article-title":"Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis","volume":"23","author":"Czaja","year":"2003","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.cld.2014.09.005_bib60","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib61","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cld.2012.12.006","article-title":"Cholestatic liver disease overlap syndromes","volume":"17","author":"Mayo","year":"2013","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib62","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cld.2012.11.007","article-title":"IgG4-associated cholangitis","volume":"17","author":"Silveira","year":"2013","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2014.09.005_bib63","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ajg.2011.375","article-title":"The spectrum of sclerosing cholangitis and the relevance of IgG4 elevations in routine practice","volume":"107","author":"Alswat","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.cld.2014.09.005_bib64","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2014.09.005_bib65","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","article-title":"Drug-induced autoimmune-like hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.cld.2014.09.005_bib66","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cld.2013.07.015","article-title":"Drug-induced cholestasis","volume":"17","author":"Bhamidimarri","year":"2013","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2014.09.005_bib67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12109","article-title":"Review article: herbal and dietary supplement hepatotoxicity","volume":"37","author":"Bunchorntavakul","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cld.2014.09.005_bib68","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bpg.2011.09.008","article-title":"Liver transplantation in autoimmune liver diseases","volume":"25","author":"Ilyas","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2014.09.005_bib69","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/liv.12027","article-title":"Liver transplantation for overlap syndromes of autoimmune liver diseases","volume":"33","author":"Bhanji","year":"2013","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.cld.2014.09.005_bib70","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1872-034X.2012.01018.x","article-title":"Living-donor liver transplantation for autoimmune hepatitis and autoimmune hepatitis-primary biliary cirrhosis overlap syndrome","volume":"42","author":"Yamashiki","year":"2012","journal-title":"Hepatol Res"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326114000877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326114000877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T10:58:22Z","timestamp":1538045902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326114000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1089326114000877"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2014.09.005","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Management of Overlap Syndromes","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2014.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}